FRANCISCO J. DE LA SERNA TORROBA-rekin lankidetzan egindako argitalpenak (2)

2021

  1. Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM)

    PLoS ONE, Vol. 16, Núm. 9 September

2018

  1. A novel ex vivo high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia

    Oncotarget, Vol. 9, Núm. 40, pp. 26019-26031